Skip to main content

The TOXIN knowledge graph: supporting animal-free risk assessment of cosmetics.

Database : the journal of biological databases and curation2025-01-29PubMed
Total: 73.5Innovation: 8Impact: 8Rigor: 6Citation: 9

Summary

This resource paper presents the TOXIN knowledge graph, an ontology-driven platform integrating SCCS cosmetic ingredient data, study reliability scoring, chemical identifiers, and QSAR predictions to support animal-free risk assessment. Populated with 88 ingredients, it flagged 53 compounds with liver toxicity signals and connected findings to adverse outcome pathways like hepatic cholestasis.

Key Findings

  • Built an ontology-based knowledge graph integrating SCCS opinions (2009–2019), ToxRTool reliability, SMILES, and OECD QSAR Toolbox.
  • Populated with 88 cosmetic ingredients and identified 53 compounds affecting at least one liver toxicity parameter in 90-day studies.
  • Linked findings to adverse outcome pathways, exemplified by hepatic cholestasis for one compound.
  • Provided interactive visualization and filtering to surface liver toxicity–related compounds for NGRA.

Clinical Implications

While not a clinical study, the tool can prioritize cosmetic ingredients for human-relevant in vitro testing, streamline hazard assessment, and reduce reliance on animal data, informing safer product development.

Why It Matters

It provides a reusable, interoperable data infrastructure that operationalizes NGRA/NAMs for cosmetics safety, addressing the regulatory need to replace animal tests with mechanistic human-relevant evidence.

Limitations

  • Current coverage limited to SCCS-derived data and primarily liver-focused endpoints.
  • Signals require confirmation with human-relevant NAMs; exposure and dose-response integration are pending.

Future Directions

Expand ingredient coverage, incorporate exposure/dose-response and uncertainty quantification, and prospectively validate KG-derived hypotheses with human NAMs within NGRA workflows.

Study Information

Study Type
Systematic Review
Research Domain
Prevention
Evidence Level
V - Methodological/resource paper integrating datasets; no direct clinical outcomes.
Study Design
OTHER